TherapeuticsMD, Inc. TXMD
1.74 USD +0.05 (+2.96%)
At closeNov 10, 2026, 4:00 PM EST
1.73 -0.01 -0.57%
After hours · Nov 10, 4:00 PM ET
1.73 Day range 1.75
1.36 52-week range 2.95
- YTD
- +6.75%
- 1 year
- +28.89%
TXMD revenue history
Revenue is income from the company’s ordinary business activities.
3,022,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,022,000 | 1,261,000 | 71.61% |
| FY 2024 | 2024-12-31 | 1,761,000 | 459,000 | 35.25% |
| FY 2023 | 2023-12-31 | 1,302,000 | -68,661,000 | -98.14% |
| FY 2022 | 2022-12-31 | 69,963,000 | 67,390,000 | 2619.12% |
| FY 2021 | 2021-12-31 | 2,573,000 | -62,299,000 | -96.03% |
| FY 2020 | 2020-12-31 | 64,872,000 | 15,225,000 | 30.67% |
| FY 2019 | 2019-12-31 | 49,647,000 | 33,547,540 | 208.38% |
| FY 2018 | 2018-12-31 | 16,099,460 | -678,253 | -4.04% |
| FY 2017 | 2017-12-31 | 16,777,713 | -2,578,737 | -13.32% |
| FY 2016 | 2016-12-31 | 19,356,450 | -786,448 | -3.90% |
| FY 2015 | 2015-12-31 | 20,142,898 | 5,116,679 | 34.05% |
| FY 2014 | 2014-12-31 | 15,026,219 | 6,250,621 | 71.23% |
| FY 2013 | 2013-12-31 | 8,775,598 | 4,957,585 | 129.85% |
| FY 2012 | 2012-12-31 | 3,818,013 | 1,729,836 | 82.84% |
| FY 2011 | 2011-12-31 | 2,088,177 | 846,256 | 68.14% |
| FY 2010 | 2010-12-31 | 1,241,921 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:39.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.